Barozi V, Tastan Bishop O
Int J Mol Sci. 2025; 26(3).
PMID: 39941135
PMC: 11818624.
DOI: 10.3390/ijms26031367.
Olivero N, Zappia V, Gargantini P, Human-Gonzalez C, Raya-Plasencia L, Marquez J
Viruses. 2025; 16(12.
PMID: 39772187
PMC: 11680156.
DOI: 10.3390/v16121877.
Bbosa N, Kiiza R, Ssekagiri A, Namagembe H, Nabirye S, Kabuuka D
Viruses. 2025; 16(12).
PMID: 39772170
PMC: 11680199.
DOI: 10.3390/v16121860.
Li X, Zhu H, Xu P, Zhang J, Wang Z, He H
Front Immunol. 2025; 15:1486352.
PMID: 39742285
PMC: 11685115.
DOI: 10.3389/fimmu.2024.1486352.
Wasim R, Sumaiya , Ahmad A
Inflammopharmacology. 2024; 33(1):1-10.
PMID: 39714724
DOI: 10.1007/s10787-024-01627-4.
Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 2023.
Zhang H, Li B, Sun J, Zou L, Yi L, Lin H
Virol J. 2024; 21(1):298.
PMID: 39568037
PMC: 11577657.
DOI: 10.1186/s12985-024-02573-x.
Evaluation of Angiotensin-Converting Enzyme 2 Expression with Novel Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain.
Li L, Wang R, He L, Guo H, Fu L, Wang G
ACS Pharmacol Transl Sci. 2024; 7(10):3119-3130.
PMID: 39416971
PMC: 11475584.
DOI: 10.1021/acsptsci.4c00316.
Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India.
Dhankher S, Yadav P, Sharma S, Gupta E, Yadav R, Dash P
Front Med (Lausanne). 2024; 11:1416006.
PMID: 39323472
PMC: 11422100.
DOI: 10.3389/fmed.2024.1416006.
The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice.
Yang J, Fan H, Yang A, Wang W, Wan X, Lin F
Vaccines (Basel). 2024; 12(7).
PMID: 39066379
PMC: 11281458.
DOI: 10.3390/vaccines12070742.
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.
Li X, Mi Z, Liu Z, Rong P
Front Microbiol. 2024; 15:1334152.
PMID: 38939189
PMC: 11208693.
DOI: 10.3389/fmicb.2024.1334152.
Development of the second version of Global Prediction System for Epidemiological Pandemic.
Huang J, Zhang L, Chen B, Liu X, Yan W, Zhao Y
Fundam Res. 2024; 4(3):516-526.
PMID: 38933188
PMC: 11197730.
DOI: 10.1016/j.fmre.2023.02.030.
The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China.
Liao Y, Su J, Zhao J, Qin Z, Zhang Z, Gao W
Front Immunol. 2024; 15:1359380.
PMID: 38881892
PMC: 11176464.
DOI: 10.3389/fimmu.2024.1359380.
The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality - Hong Kong SAR, China, 2022.
Zeng Z, Liang J, Lin Z, Guan W, He W, Li Q
China CDC Wkly. 2024; 6(21):469-477.
PMID: 38854464
PMC: 11154106.
DOI: 10.46234/ccdcw2024.092.
Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19.
Zheng Z, Sun H, Hu X, Xuan Z, Fu M, Bai Y
Front Med (Lausanne). 2024; 11:1287836.
PMID: 38633308
PMC: 11021598.
DOI: 10.3389/fmed.2024.1287836.
SARS-CoV-2 and Its Omicron Variants Detection with RT-RPA -CRISPR/Cas13a-Based Method at Room Temperature.
Li J, Wang X, Chen L, Duan L, Tan F, Li K
Rep Biochem Mol Biol. 2024; 12(3):425-437.
PMID: 38618265
PMC: 11015926.
DOI: 10.61186/rbmb.12.3.425.
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants.
Chen L, He Y, Liu H, Shang Y, Guo G
Front Immunol. 2024; 15:1339660.
PMID: 38464527
PMC: 10924305.
DOI: 10.3389/fimmu.2024.1339660.
A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.
Shi J, Zheng J, Zhang X, Tai W, Compas R, Deno J
JCI Insight. 2024; 9(5).
PMID: 38456504
PMC: 10972590.
DOI: 10.1172/jci.insight.155789.
Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children.
Martignoni M, Mohammadi Z, Loredo-Osti J, Hurford A
Can Commun Dis Rep. 2024; 49(4):155-165.
PMID: 38390394
PMC: 10883462.
DOI: 10.14745/ccdr.v49i04a08.
A conformal regressor for predicting negative conversion time of Omicron patients.
Wang P, Wu S, Tian M, Liu K, Cong J, Zhang W
Med Biol Eng Comput. 2024; .
PMID: 38363486
DOI: 10.1007/s11517-024-03029-8.
tANCHOR cell-based ELISA approach as a surrogate for antigen-coated plates to monitor specific IgG directed to the SARS-CoV-2 receptor-binding domain.
Bernauer H, Maier J, Bannert N, Ivanusic D
Biol Methods Protoc. 2024; 9(1):bpae001.
PMID: 38332985
PMC: 10850845.
DOI: 10.1093/biomethods/bpae001.